Cart
sales@molnova.com
Tacrine
CAS No. 321-64-2
Tacrine( CS 12602 | Tacrinum )
Catalog No. M24254 CAS No. 321-64-2
Tacrine is an indirect cholinergic agonist and centrally acting anticholinesterase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 92 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 183 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 368 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTacrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTacrine is an indirect cholinergic agonist and centrally acting anticholinesterase.
-
DescriptionTacrine is an indirect cholinergic agonist and centrally acting anticholinesterase. It is approved for the treatment of Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
SynonymsCS 12602 | Tacrinum
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorCholinergic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number321-64-2
-
Formula Weight198.26
-
Molecular FormulaC13H14N2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble; Water:Insoluble
-
SMILESNc1c(CCCC2)c2nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, Campiani G, Filipic S, Agbaba D, Esteban G, Unzeta M, Nikolic K, Butini S, Marco-Contelles J. Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease. Prog Neurobiol. 2016 Jan 18. pii: S0301-0082(15)00162-8. doi: 10.1016/j.pneurobio.2015.12.003. [Epub ahead of print] Review.
molnova catalog
related products
-
JHU 37160
JHU 37160 is a Designer Receptors Exclusively Activated by Designer Drug (DREADD) agonist with Ki of 1.9 nM and 3.6 nM for human muscarinic acetylcholine M3 receptors (hM3Dq) and hM4Di in vitro, respectively.
-
CCMI
CCMI is a potent and selective modulator of α7 nAChR-positive allosteric.
-
α-Bungarotoxin
Neurotoxin that blocks neuromuscular transmission via irreversible inhibition of nicotinic ACh receptors (nAChRs). Prevents opening of nicotinic receptor-associated ion channels and is selective for α7 receptors over α3β4 receptors (IC50 values are 1.6 nM and > 3 μM respectively).
